What changed, and why does it matter?
Understand what a competitor’s announcement or market move could change for your business. Trace the evidence, consider other explanations and decide what to investigate next.
- Question
- Define the decision
- Support
- Trace original sources
- Limit
- Show conflicts and unanswered questions
- Action
- Test before commitment
What is visible?
Published market and company records support a market. They do not establish a buyer-specific award decision.
Visibility is not verification.
The finding carries its sources, disagreements and remaining checks into the commercial decision.
Repetition is not independent corroboration. How well a claim is supported and our confidence remain separate.
Competitor information is easy to collect and difficult to interpret.
A new factory announcement may represent genuine capacity, a future plan or little more than corporate signaling. A product launch may indicate strategic expansion, a defensive response or a narrow local experiment. Hiring growth may suggest investment, but not necessarily commercial success.
PhaseVane turns observable competitor and market signals into a bounded commercial decision view.
The objective is not to claim privileged knowledge of competitor intent.
It is to answer:
What changed? What evidence supports it? What alternative explanations exist? How confident should the buyer be? What commercial action does the change justify?
Observable evidence first.
A competitor may:
- announce a plant;
- increase hiring;
- enter a new geography;
- add a product line;
- change distribution;
- acquire capacity;
- alter pricing;
- change suppliers.
These are observable or documentable developments.
The analyst can infer possible commercial implications, but should preserve the distinction between:
what is known
and:
what the analyst believes it may mean
That boundary is central to credible competitive intelligence.
Research should be tied to an action.
Examples:
Does Competitor X’s new facility materially change capacity in this market?
Is a new product launch likely to intensify price competition in our segment?
Has the competitive set shifted enough to require a sourcing or go-to-market response?
Is a competitor's apparent expansion supported by operating evidence?
Without a decision boundary, competitor research becomes endless monitoring.
- 01
Decision Question
Bound the commercial choice.
- 02
Evidence
Keep sources and states attached.
- 03
Contradiction
Record what does not agree.
- 04
Confidence / Gaps
Expose the limit of the finding.
- 05
Commercial Implication
Show what changes for the buyer.
- 06
Action
Proceed, test, hold or investigate.
Competitive evidence should come from traceable signals.
Depending on the question, sources may include:
- company filings;
- press releases;
- official registries;
- plant announcements;
- planning records;
- trade data;
- hiring data;
- distributor changes;
- product documentation;
- patents;
- tenders;
- customer communications;
- industry media;
- supplier evidence;
- pricing observations.
Each source has limits.
A press release can document an announcement.
It does not prove completion.
A hiring page can indicate demand for talent.
It does not prove sales growth.
Capacity claims need stage classification.
A competitor says it is building a new plant.
The commercially relevant questions are:
- funded?
- permitted?
- under construction?
- equipment installed?
- commissioning?
- operating?
- ramped?
An announced 100,000-unit facility should not be counted as 100,000 units of current competitive capacity.
PhaseVane should classify the stage explicitly.
A launch can mean several things.
A new product can indicate:
- adjacent-category expansion;
- customer response;
- geographic adaptation;
- technology shift;
- defensive move.
The research should look for supporting evidence:
- channel expansion;
- new certifications;
- hiring;
- supply agreements;
- customer wins;
- production changes.
The interpretation should strengthen only when multiple independent signals align.
Competitor pricing is rarely transparent.
Observable pricing may come from:
- tenders;
- distributors;
- published price lists;
- quotes;
- channel checks;
- public procurement records where relevant.
But the analyst must preserve:
- quantity;
- specification;
- geography;
- date;
- channel;
- terms.
A price seen in one channel should not be generalised to the entire market.
Competitor advantage can begin upstream.
A company may gain or lose advantage through:
- long-term material contracts;
- captive production;
- vertical integration;
- new suppliers;
- logistics routes;
- geographic diversification.
This can affect:
- cost;
- resilience;
- lead time;
- capacity.
Where public evidence exists, PhaseVane should connect the upstream move to the buyer’s commercial question.
- 01
Decision Question
Bound the commercial choice.
- 02
Evidence
Keep sources and states attached.
- 03
Contradiction
Record what does not agree.
- 04
Confidence / Gaps
Expose the limit of the finding.
- 05
Commercial Implication
Show what changes for the buyer.
- 06
Action
Proceed, test, hold or investigate.
Signals often conflict.
Example:
Signal A: competitor announces major expansion.
Signal B: hiring remains flat.
Signal C: supplier activity increases.
Signal D: construction evidence confirms partial build.
The report should not force a clean narrative.
It should say:
Expansion appears real, but current operating scale remains uncertain.
That is more useful than overclaiming either success or failure.
Strong narratives need strong evidence.
PhaseVane should assign confidence to each material interpretation.
For example:
- High confidence: facility construction is active.
- Moderate confidence: expansion is intended for the target product line.
- Low confidence: capacity will materially change market pricing within 12 months.
That prevents the report from overstating what public evidence can actually support.
Competitive intelligence matters only if it changes action.
Possible implications include:
- accelerate supplier diversification;
- investigate new capacity;
- pressure-test pricing assumptions;
- monitor one dependency;
- delay investment;
- narrow the competitor set;
- gather direct customer/channel evidence;
- take no action because the observed move is immaterial.
The best output is often a smaller next step, not a sweeping strategic recommendation.
A competitor announces a new production facility.
Evidence:
- company announcement;
- local planning records;
- construction imagery;
- recruitment for plant roles.
Unknown:
- final product mix;
- commissioning date;
- stable output;
- customer allocation.
Contradiction:
- no corresponding export growth yet.
PhaseVane conclusion:
INVESTIGATE NEXT. The expansion appears operationally credible, but the timing and product allocation are not yet strong enough to assume immediate market-capacity pressure.
Commercial next step:
- monitor commissioning;
- check hiring;
- track trade activity;
- test customer/channel evidence.
Depending on scope:
- decision question;
- competitor/event timeline;
- evidence register;
- signal classification;
- contradiction register;
- confidence view;
- commercial implication;
- monitoring priorities;
- next action.